Table 2.
Diagnostic performance of the β-glucan assay for the detection of invasive fungal diseases.
| Clinical Papers | Sensitivity (%) | Specificity (%) | Evidence | β-Glucan Assay Kits | |
|---|---|---|---|---|---|
| Obayashi, T., et al. [10] | 90 | 100 | Multi-center clinical studies, 9 sites | Japan | Fungitec G-test |
| Ostrosky-Zeichner, L., et al. [11] | 70 | 87 | Multi-center clinical evaluation, 6 sites | USA | Fungitell |
| Lu, Y., et al. [76] | 76 | 85 | 13 ** | Fungitell (9/13) | |
| WAKO (2/13) | |||||
| Fungitec G-test (1/13) | |||||
| Karageorgopoulos, D.E., et al. [77] | 77 | 85 | 23 ** | Fungitell (10/23) | |
| Fungitec G-test (7/23) | |||||
| WAKO (5/23) | |||||
| Meta-analysis * | Gold Mountain River (1/23) | ||||
| Onishi, A., et al. [78] | 80 | 82 | 36 ** | Fungitell (17/36) | |
| Fungitec G-test (9/36) WAKO (6/36) |
|||||
| Gold Mountain River (3/36) Others (1/36) |
|||||
| White, S.K., et al. [79] | 83 | 79 | 19 ** | Fungitell (19/19) | |
* Multicenter cohort study, Multicenter case-control study, Prospective cohort study, Prospective case-control study, Retrospective cohort study, Retrospective case-control study, etc. ** Total number of articles.